SAA does not induce cytokine production in physiological conditions

Cytokine

Volumn 61, Issue 2, 2013, Pages 506-512

  Kim, Myung Hee ^a   de Beer, Maria C ^a   Wroblewski, Joanne M ^a   Webb, Nancy R ^a,c   de Beer, Frederick C ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Acute phase; Cytokine; G CSF; HDL; SAA

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTECTIVE AGENTS; SERUM AMYLOID A PROTEIN; TOLL-LIKE RECEPTOR 2;

MUS;

EID: 84873101814     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.019     Document Type: Article

References (34)

1. Van Lenten B.J., Reddy S.T., Navab M., Fogelman A.M. Understanding changes in high density lipoproteins during the acute phase response. Arterioscler Thromb Vasc Biol 2006, 26:1687-1688.
2. Coetzee G.A., Strachan A.F., van der Westhuyzen D.R., Hoppe H.C., Jeenah M.S., de Beer F.C. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 1986, 261:9644-9651.
3. Koga T., Torigoshi T., Motokawa S., Miyashita T., Maeda Y., Nakamura M., et al. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett 2008, 582:579-585.
4. Song C., Hsu K., Yamen E., Yan W., Fock J., Witting P.K., et al. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009, 207:374-383.
5. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999, 265:501-523.
6. Bjorkman L., Raynes J.G., Shah C., Karlsson A., Dahlgren C., Bylund J. The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation. Arthritis Rheum 2010, 62:1660-1665.
7. Jahangiri A., de Beer M.C., Noffsinger V., Tannock L.R., Ramaiah C., Webb N.R., et al. HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 2009, 29:261-267.
8. de Beer M.C., Webb N.R., Wroblewski J.M., Noffsinger V.P., Rateri D.L., Ji A., et al. Impact of serum amyloid A on high density lipoprotein composition and levels. J Lipid Res 2010, 51:3117-3125.
9. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
10. Strachan A.F., Brandt W.F., Woo P., van der Westhuyzen D.R., Coetzee G.A., de Beer M.C., et al. Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem 1989, 264:18368-18373.
11. Strachan A.F., Shephard E.G., Bellstedt D.U., Coetzee G.A., van der Westhuyzen D.R., de Beer F.C. Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production. Biochem J 1989, 263:365-370.
12. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95:2509-2514.
13. Liao W., Floren C.H. Complexes with and cationizes low density lipoproteins. The cause of polymyxin B-induced enhancement of endocytotic catabolism of low density lipoproteins. Biochem Pharmacol 1993, 45:1835-1843.
14. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 2008, 181:22-26.
15. He R.L., Zhou J., Hanson C.Z., Chen J., Cheng N., Ye R.D. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009, 113:429-437.
16. Sprong T., Netea M.G., van der Ley P., Verver-Jansen T.J., Jacobs L.E., Stalenhoef A., et al. Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria. J Lipid Res 2004, 45:742-749.
17. Van Leeuwen H., van Isterdael M., Van Strijp J., Van Kessel K., Verhoef J. The role of serum amyloid A (Saa) in sepsis and LPS neutralization. Crit Care Med 1998, 26:130A.
18. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994, 180:203-209.
19. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 2004, 50:1788-1799.
20. Patel H., Fellowes R., Coade S., Woo P. Human serum amyloid A has cytokine-like properties. Scand J Immunol 1998, 48:410-418.
21. de Beer M.C., de Beer F.C., McCubbin W.D., Kay C.M., Kindy M.S. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993, 268:20606-20612.
22. Patel H., Bramall J., Waters H., De Beer M.C., Woo P. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996, 318(Pt 3):1041-1049.
23. Hareng L., Hartung T. Induction and regulation of endogenous granulocyte colony-stimulating factor formation. Biol Chem 2002, 383:1501-1517.
24. He R., Sang H., Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003, 101:1572-1581.
25. Bjorkman L., Karlsson J., Karlsson A., Rabiet M.J., Boulay F., Fu H., et al. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J Leukoc Biol 2008, 83:245-253.
26. Mullan R.H., McCormick J., Connolly M., Bresnihan B., Veale D.J., Fearon U. A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A. Am J Pathol 2010, 176:1999-2008.
27. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J Leukoc Biol 2008, 83:1174-1180.
28. Chiba T., Chang M.Y., Wang S., Wight T.N., McMillen T.S., Oram J.F., et al. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler Thromb Vasc Biol 2011, 31:1326-1332.
29. Yu J., Zhu H., Guo J.T., de Beer F.C., Kindy M.S. Expression of mouse apolipoprotein SAA1.1 in CE/J mice. isoform-specific effects on amyloidogenesis. Lab Invest 2000, 80:1797-1806.
30. Dong Z., Wu T., Qin W., An C., Wang Z., Zhang M., et al. Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Mol Med 2011, 17:1357-1364.
31. Tobias P.S., Ulevitch R.J. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). J Immunol 1983, 131:1913-1916.
32. Vishnyakova T.G., Bocharov A.V., Baranova I.N., Chen Z., Remaley A.T., Csako G., et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 2003, 278:22771-22780.
33. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999, 104:R25-R31.
34. van der Westhuyzen D.R., Cai L., de Beer M.C., de Beer F.C. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005, 280:35890-35895.